Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Cells|May 21, 2020
TNFα Rescues Dendritic Cell Development in Hematopoietic Stem and Progenitor Cells Lacking C/EBPαSubramanian Anirudh, Angelika Rosenberger, Elke Schwarzenberger, et al.
International Journal of Molecular Sciences|October 26, 2024
Limited Alleviation of Lysosomal Acid Lipase Deficiency by Deletion of Matrix Metalloproteinase 12Martin Buerger, Melina Amor, Alena Akhmetshina, et al.
Cancer Medicine|March 9, 2019
High GPR56 surface expression correlates with a leukemic stem cell gene signature in CD34-positive AMLShruti Daga, Angelika Rosenberger, Franz Quehenberger, et al.
Obesity (Silver Spring, Md.)|May 15, 2013
Primary antiphospholipid antibody syndrome-one further aspect of thrombophilia in overweight and obese patients with venous thromboembolismThomas Gary, Klara Belaj, Rosa Bruckenberger, et al.
Cancers|March 14, 2020
Functional Classification of TP53 Mutations in Acute Myeloid LeukemiaSayantanee Dutta, Gudrun Pregartner, Frank G Rücker, et al.
Experimental Hematology|April 24, 2025
Engineered cytokine-expressing MSCs support ex vivo culture of human HSPCs and AML cellsJohannes Foßelteder, Thomas Brauchart, Angelika Schlacher, et al.
Haematologica|September 18, 2012
Rituximab plus subcutaneous cladribine in patients with extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue: a phase II study by the Arbeitsgemeinschaft Medikamentose TumortherapieMarlene Troch, Barbara Kiesewetter, Wolfgang Willenbacher, et al.
Cancers|February 26, 2020
Increased Expression of Micro-RNA-23a Mediates Chemoresistance to Cytarabine in Acute Myeloid LeukemiaStefan Hatzl, Bianca Perfler, Sonja Wurm, et al.
Haematologica|October 13, 2018
Clinical implications of subclonal TP53 mutations in acute myeloid leukemiaKatharina T Prochazka, Gudrun Pregartner, Frank G Rücker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 23, 2026
A novel potent and selective GCN2 inhibitor, APL-4098, has anti-leukemic activity through dysregulation of mitochondrial functionMonica Román-Trufero, Gavin Whitlock, Claire Seydoux, et al.
Pageof 6